Mustang Bio
MBIO
95 hedge funds and large institutions have $80.5M invested in Mustang Bio in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 12 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 23
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
7% more capital invested
Capital invested by funds: $75.3M → $80.5M (+$5.21M)
2% more funds holding
Funds holding: 93 → 95 (+2)
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
17% less call options, than puts
Call options by funds: $832K | Put options by funds: $1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$5.06M |
| 2 |
JP Morgan Chase
New York
|
+$3.39M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.35M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.21M |
| 5 |
Renaissance Technologies
New York
|
+$2.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$3.38M |
| 2 |
Millennium Management
New York
|
-$2.54M |
| 3 |
6CM
683 Capital Management
New York
|
-$1.74M |
| 4 |
Squarepoint
New York
|
-$961K |
| 5 |
TI
Telemetry Investments
New York
|
-$564K |
MBIO Hedge Fund Activity: Q1 2021 in Review
95 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2021, worth a combined $80.5M — up 6.9% from $75.3M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MBIO positions and 12 closed out — a net gain of 2 holders — while 34 added to existing stakes and 23 trimmed.
The largest buyer was Nuveen, adding an estimated $5.06M. The largest seller was Endurant Capital Management, exiting entirely with an estimated $3.38M sold.
- 95 institutional investors held Mustang Bio (MBIO) as of Q1 2021, up from 93 in Q4 2020.
- Funds reported $80.5M of Mustang Bio stock for Q1 2021, up 6.9% quarter-over-quarter.
- 14 funds opened new Mustang Bio positions in Q1 2021 and 12 closed out, a net change of +2 holders.
- The largest Mustang Bio buyer in Q1 2021 was Nuveen, an estimated $5.06M added.
- The largest Mustang Bio seller in Q1 2021 was Endurant Capital Management, an estimated $3.38M sold.
Based on aggregated 13F filings for Q1 2021.